® brand and the global leader of collagen-based solutions
1, announces the reopening of its upgraded Brazilian innovation lab. Recently upgraded to serve the growing need for best-in-class application support across the food and nutrition, and pharmaceutical markets, the lab is located in Amparo/SP, Brazil, on Rousselot s current Peptan
® collagen peptides manufacturing site. In a strategic move to further strengthen its world-leading lab network, which already includes the global lab in Ghent s Expertise Center located in Belgium and the regional lab in Wenzhou, China; Rousselot confirms its commitment to bring cutting edge, innovative application support to customers all over the world.
Sevaro Partners with Local Coffee Shops to Educate the Public on How to Spot Stroke
- Coffee Cup Sleeves will display the BEFAST Acronym -
News provided by
Share this article
Share this article
NEW YORK, May 3, 2021 /PRNewswire/ Sevaro Health, a leader in telestroke and teleneurology is partnering with coffee shops across the country during the month of May which is Stroke Awareness Month. The effort will aim to educate 14,000 coffee shop customers on how to identify an individual who may be suffering from a stroke. Adorning the coffee cup sleeve with the BEFAST acronym will allow baristas to spread awareness on what to look for and how to react if someone is showing symptoms of a stroke as well as direct customers on how to assess their risk for stroke.
Share this article
Share this article
PALO ALTO, Calif., May 3, 2021 /PRNewswire/ Datavant, the leader in helping healthcare organizations safely connect their data, and Verantos, the market leader in regulatory-grade electronic health record (EHR)-based studies, today announced a strategic partnership to enable Verantos to utilize additional linked data sources to support its regulatory and reimbursement studies for its partners.
Verantos s platform and expertise enables its life sciences partners to use advanced real-world evidence in both regulatory and reimbursement studies. Using Datavant s privacy-protecting linking technology, Verantos can bring in additional data from a variety of real-world data sources and link these sources together. Verantos can then conduct detailed, customized analysis to determine the impact of specific therapies on patient outcomes.
Share this article
Share this article
WORCESTER, Mass., May 1, 2021 /PRNewswire/ The nurses of St. Vincent Hospital and Dallas-based Tenet Healthcare held the second round of negotiations since the nurses launched their strike on March 8 today, where Tenet for the first time made a long-awaited proposal that opens the door to a substantive discussion on the nurses main issue, which is the need for safer staffing levels to ensure safer patient care.
The nurses negotiating committee will take the next few days to meet and carefully evaluate the hospital s proposal and will be back to the table for negotiations on Wednesday at 10 a.m. to present a comprehensive response on what nurses need to settle the contract and end the strike. At this time, the nurses will not be discussing the specifics of, or the value of, what the hospital has proposed, but see it as a positive step in the process.
/PRNewswire/ Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group),.